Medical Care Technologies Inc. (MDCE) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Medical Care Technologies Inc. (MDCE) trades at $0.0001. Medical Care Technologies Inc. is a development stage company focused on establishing children's health and wellness centers in China. Sector: Financial services.
Price as of Aug 21, 2026 · Last analyzed: Mar 16, 2026Analyst Coverage for MDCE: MDCE does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates MDCE against Financial Services peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
Not enough scored data yet to form a council read on MDCE.
How is this calculated? →Medical Care Technologies Inc. (MDCE) Financial Services Profile
Medical Care Technologies Inc., operating in the financial services sector as a development stage company, focuses on establishing children's integrated health and wellness centers in China, alongside distributing pharmaceutical and nutraceutical products. The company's business model involves multiple sales channels, including online and retail.
What Is the Investment Thesis for MDCE?
Medical Care Technologies Inc. presents a speculative investment opportunity given its status as a development stage company operating in the OTC market. The company's negative P/E ratio of -276.78 and a negative profit margin of -0.4% indicate ongoing losses. The company's future hinges on its ability to successfully establish and scale its children's health and wellness centers in China. Key value drivers include successful market penetration, effective cost management, and the ability to generate sustainable revenue streams. The company's beta of -0.32 suggests a low correlation with the overall market, which could offer diversification benefits. However, investors should be aware of the risks associated with investing in OTC-listed, development stage companies with limited financial resources. The company's long-term success depends on its ability to secure funding and execute its business plan effectively.
Based on FMP financials and quantitative analysis
MDCE Key Highlights
Market capitalization of $0.00B indicates a micro-cap company with limited financial resources.
- P/E ratio of -276.78 reflects negative earnings and suggests the company is not currently profitable.
- Gross margin of 20.7% indicates the percentage of revenue exceeding the cost of goods sold.
- Profit margin of -0.4% shows the company is operating at a loss.
- Beta of -0.32 suggests the stock has a low correlation with the overall market.
Who Are MDCE's Competitors?
MDCE is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CAVG ACC Aviation Holdings Ltd. | $0.61 | +0.00% | $303M | 44 |
| NIHL New Infinity Holdings, Ltd. | $0.10 | +0.00% | $10.8M | 62 |
| LRGR Luminar Media Group, Inc. | $0.50 | +47.06% | $22.4M | 68 |
| CLAYU Chavant Capital Acquisition Corp. | $10.97 | +18.34% | $27.5M | 62 |
| CLAY Chavant Capital Acquisition Corp. | $10.66 | +6.39% | $29.6M | 62 |
| INACU Indigo Acquisition Corp. | $12.08 | +16.94% | $34.9M | 60 |
| HHGC HHG Capital Corporation | $11.12 | +0.09% | $56.2M | 63 |
| MAAQ Mana Capital Acquisition Corp. | $5.99 | -24.18% | $57.0M | 61 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are MDCE's Key Strengths?
Focus on the growing Chinese healthcare market.
- Multiple distribution channels.
- Potential for brand recognition.
- Proprietary children's health and wellness center model.
What Are MDCE's Weaknesses?
Development stage company with limited operating history.
- Negative profitability.
- Small size and limited resources.
- Reliance on external funding.
What Could Drive MDCE Stock Higher?
Potential partnerships with established healthcare providers in China.
- Expansion into new geographic markets within China.
- Development and launch of new pharmaceutical and nutraceutical products.
- Increasing brand awareness through marketing and promotional activities.
- Regulatory approvals for new health and wellness centers.
What Are the Key Risks for MDCE?
Financial-distress signal — its Altman Z-Score of -2.80 sits in the distress zone (elevated bankruptcy risk).
- Inability to secure additional funding to support growth initiatives.
- Intense competition from established healthcare providers in China.
- Regulatory changes that could impact the company's operations.
- Limited operating history and financial resources.
- Dependence on key personnel.
What Are the Growth Opportunities for MDCE?
- Expansion of Children's Health and Wellness Centers: Medical Care Technologies Inc. can grow by expanding its network of children's health and wellness centers across China. The Chinese healthcare market is experiencing rapid growth, driven by increasing disposable incomes and a growing awareness of health and wellness. The company can capitalize on this trend by establishing new centers in strategic locations and offering a comprehensive range of services. The timeline for expansion depends on the company's ability to secure funding and navigate regulatory hurdles.
- Online Sales and Distribution: The company can leverage its website to expand its online sales and distribution channels. E-commerce is a rapidly growing sector in China, and Medical Care Technologies Inc. can tap into this market by offering its products online. This would allow the company to reach a wider customer base and reduce its reliance on traditional retail channels. The timeline for expanding online sales depends on the company's ability to develop a user-friendly website and implement effective marketing strategies. The e-commerce market in China is one of the largest in the world.
- Strategic Partnerships: Medical Care Technologies Inc. can form strategic partnerships with other healthcare providers, pharmaceutical companies, and retailers to expand its reach and product offerings. These partnerships can provide access to new markets, technologies, and resources. The timeline for forming strategic partnerships depends on the company's ability to identify and negotiate mutually beneficial agreements. The healthcare industry is characterized by a high degree of collaboration and partnerships.
- Product Diversification: The company can diversify its product offerings to include a wider range of healthcare products and services. This could include developing new pharmaceutical and nutraceutical products, offering specialized healthcare services, or expanding into related areas such as medical devices. The timeline for product diversification depends on the company's ability to conduct research and development and obtain regulatory approvals. The healthcare market is constantly evolving, and companies need to innovate to stay ahead of the competition.
- Franchising Opportunities: Medical Care Technologies Inc. could explore franchising its health and wellness center model to accelerate expansion and leverage local expertise. Franchising can provide a capital-efficient way to grow the business and tap into the entrepreneurial spirit of local operators. The timeline for implementing a franchising model depends on the company's ability to develop a standardized operating model and attract qualified franchisees. The franchising market in China is growing rapidly, driven by increasing entrepreneurship and a desire for proven business models.
What Are MDCE's Competitive Advantages?
- Proprietary children's health and wellness center model.
- Established distribution network in China.
- Brand recognition in the Chinese healthcare market.
- Relationships with key stakeholders, including healthcare providers and pharmaceutical companies.
What Does MDCE Do?
Medical Care Technologies Inc., founded in 2007 and headquartered in Beijing, China, operates as a development stage company with a focus on the healthcare sector in China. The company's primary business involves establishing and operating children's integrated health and wellness centers. These centers aim to provide a range of health-related services and products tailored to children. In addition to its wellness centers, Medical Care Technologies Inc. engages in the sale and distribution of pharmaceutical and nutraceutical products. These products include over-the-counter medicines, herbal products, personal care items, and family care products. The company distributes its products through various channels, including its own pediatric health and wellness centers, its website, retail pharmacies, and direct sales representatives. Medical Care Technologies Inc. serves a diverse customer base, including retail pharmacies, pharmaceutical companies, hospitals, physicians' offices, and individual consumers. The company also caters to industrial and food microbiology laboratories. Despite its founding in 2007, the company remains in the development stage, indicating that it is still working to establish a sustainable and profitable business model. The company's small size, with only one employee, suggests that it may be heavily reliant on external partnerships or outsourcing for key functions.
What Products and Services Does MDCE Offer?
- Operates children's integrated health and wellness centers in China.
- Sells and distributes pharmaceutical products.
- Offers nutraceutical products.
- Provides over-the-counter medicines.
- Distributes herbal products.
- Sells personal care products.
- Offers family care products.
How Does MDCE Make Money?
- Generates revenue through the sale of pharmaceutical and nutraceutical products.
- Earns income from the operation of children's health and wellness centers.
- Utilizes multiple distribution channels, including online sales and retail partnerships.
What Industry Does MDCE Operate In?
Medical Care Technologies Inc. operates within the shell company industry, a segment characterized by companies that often lack substantial operations and may be involved in mergers, acquisitions, or reverse takeovers. The broader healthcare market in China presents significant opportunities due to increasing healthcare spending and demand for quality healthcare services. However, the competitive landscape is intense, with numerous domestic and international players vying for market share. Medical Care Technologies Inc.'s success depends on its ability to differentiate itself and establish a strong brand presence in the Chinese market.
Who Are MDCE's Key Customers?
- Retail pharmacies
- Pharmaceutical companies
- Hospitals
- Physicians' offices
- Consumers
- Industrial and food microbiology laboratories
Insider Activity
The most recent 4 insider filings for Medical Care Technologies Inc. break down as 2 sales and 2 purchases. On net that is roughly 179.8M shares acquired (about $94K) — insiders putting money in tends to read as conviction.
Key Financial Metrics
Return on equity for Medical Care Technologies Inc. stands at 12.4%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 10.6%, showing how much profit it generates from its asset base. MDCE trades at a trailing price-to-earnings ratio of 3.28, below the Financial Services sector average of ~18x. Its free cash flow yield is 10.6%, a gauge of the cash the business throws off relative to its market value. A current ratio of 30.24 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 30.5%, the inverse of the P/E and a quick read on earnings relative to price.
Financial Health
Medical Care Technologies Inc.'s Piotroski F-Score is 6/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -2.80 places it in the distress zone, a signal of elevated financial risk.
Company Profile
Medical Care Technologies Inc. operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in Mesa, US. The company is led by CEO Marshall Perkins. MDCE has traded publicly since 2009.
MDCE Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Focus on the growing Chinese healthcare market.
- Multiple distribution channels.
- Potential for brand recognition.
- Proprietary children's health and wellness center model.
Bear Case
- Development stage company with limited operating history.
- Negative profitability.
- Small size and limited resources.
- Reliance on external funding.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026
MDCE Latest News
No recent news available for MDCE.
MDCE Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for MDCE.
Price Targets
Wall Street price target analysis for MDCE.
MDCE MoonshotScore
What does this score mean?
The MoonshotScore rates MDCE 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Classification
Industry Shell CompaniesLeadership: Marshall Perkins
CEO
Marshall Perkins is the CEO of Medical Care Technologies Inc. Information regarding his detailed career history, educational background, and previous roles is not available in the provided data. His leadership is crucial for guiding the company through its development stage and establishing a sustainable business model in the Chinese healthcare market. His experience in the healthcare or pharmaceutical industries would be particularly valuable.
Track Record: Due to the limited information available, Marshall Perkins' specific achievements and strategic decisions as CEO of Medical Care Technologies Inc. cannot be assessed. The company's current financial situation, with negative profitability, suggests that significant challenges remain. His ability to secure funding, navigate regulatory hurdles, and drive revenue growth will be critical for the company's future success.
MDCE OTC Market Information
The OTC Other tier, where Medical Care Technologies Inc. trades, represents the lowest tier of the OTC market. Companies in this tier often have limited financial disclosure and may not meet minimum listing requirements. This tier is generally considered to be the most speculative and carries the highest risk compared to companies listed on major exchanges like the NYSE or NASDAQ, which have stringent listing standards and reporting requirements. Investing in OTC Other stocks requires a high degree of due diligence and risk tolerance.
- OTC Tier: OTC Other
- Limited financial disclosure.
- Low liquidity.
- Speculative nature of the business.
- Potential for fraud or manipulation.
- Lack of regulatory oversight.
- Verify the company's registration and legal status.
- Obtain and review available financial statements.
- Assess the company's business plan and prospects.
- Research the background and experience of the management team.
- Understand the risks associated with investing in OTC Other stocks.
- Consult with a financial advisor.
- Determine if the company is current in its filings.
- Company has been in operation since 2007.
- Focus on a specific market niche (children's health and wellness).
- Presence of a CEO (Marshall Perkins).
Medical Care Technologies Inc. Financial Services Stock: Key Questions Answered
What does Medical Care Technologies Inc. do?
Medical Care Technologies Inc. is a development stage company focused on establishing and operating children's integrated health and wellness centers in China. In addition to its wellness centers, the company sells and distributes pharmaceutical and nutraceutical products, including over-the-counter medicines, herbal products, and personal care items.
What do analysts say about MDCE stock?
As of March 16, 2026, there is no available analyst coverage for Medical Care Technologies Inc. (MDCE). Given its OTC listing and development stage status, the company is unlikely to be followed by major research firms. Investors should conduct their own due diligence and carefully consider the risks and opportunities associated with investing in this stock.
What are the main risks for MDCE?
Medical Care Technologies Inc. faces several significant risks, primarily stemming from its status as a development stage company operating in the OTC market. These risks include limited financial resources, negative profitability, intense competition in the Chinese healthcare market, and regulatory hurdles. The company's reliance on external funding makes it vulnerable to changes in investor sentiment and capital market conditions.
What are the key factors to evaluate for MDCE?
Evaluate MDCE on fundamentals, analyst consensus, and risk factors. Medical Care Technologies Inc. presents a speculative investment opportunity given its status as a development stage company operating in the OTC market. Not financial advice.
How frequently does MDCE data refresh on this page?
MDCE's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven MDCE's recent stock price performance?
Medical Care Technologies Inc. (MDCE) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Focus on the growing Chinese healthcare market. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider MDCE overvalued or undervalued right now?
Medical Care Technologies Inc. (MDCE) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research MDCE before investing?
Before investing in Medical Care Technologies Inc. (MDCE), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available on the company's financials and operations.
- OTC listing increases the risk of investing in this stock.
- Development stage company with a limited operating history.